Summit Therapeutics Inc. (SMMT)
BMV
Closed
Oct 7, 2026
Day's Range
290.1252 wk Range
281.00Overview - SMMT - Summit Therapeutics Inc.
Key Statistics
Valuation
Enterprise Value
4.19T
P/E (Trailing)
‪-201.47‬
PEG Ratio
‪3.18‬
Price / Book
‪21.50‬
EV / EBITDA
‪-263.84‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-101.61%‬
Return on Equity
‪-192.50%‬
Ownership
Shares Outstanding
793.12M
Float
152.28M
Held by Insiders
‪80.89%‬
Held by Institutions
‪17.57%‬
Price stats
Beta
‪-1.24‬
50-Day Avg
‪290.12‬
200-Day Avg
‪321.88‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - SMMT - Summit Therapeutics Inc.
Peers - SMMT - Summit Therapeutics Inc.
Peer Comparison
Compared with companies in Biotechnology listed on BMV.
- SMMTBMVSummit Therapeutics Inc.231.44BMarket Cap-21.04%52-week change-201.47P/E (Trailing)‪0.00%‬Profit Margin
- ARGXNBMVargenx SE American Depositary Receipt1.05TMarket Cap+10.77%52-week change36.36P/E (Trailing)‪32.26%‬Profit Margin
- ALNYBMVAlnylam Pharmaceuticals, Inc.742.50BMarket Cap-51.02%52-week change53.47P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNBMVBioNTech SE American Depositary Share413.38BMarket Cap-18.50%52-week change1.65P/E (Trailing)‪-63.63%‬Profit Margin
- ASND1NBMVAscendis Pharma A/S291.08BMarket Cap+3.50%52-week change19.80P/E (Trailing)‪70.84%‬Profit Margin
- BMRNBMVBioMarin Pharmaceutical Inc.213.89BMarket Cap+10.22%52-week change172.39P/E (Trailing)‪2.14%‬Profit Margin
- AGIOBMVAgios Pharmaceuticals, Inc.72.95BMarket Cap+0.00%52-week change5.17P/E (Trailing)‪88.25%‬Profit Margin
Profile Summary - SMMT - Summit Therapeutics Inc.
About
Summit Therapeutics Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing therapies for serious unmet medical needs. Summit Therapeutics Inc. centers its current portfolio on oncology, with ivonescimab as its lead investigational asset, a bispecific antibody designed to combine…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
